Company: NCEL
Filing Date: 2025-03-31
Form Type: 425
Source: 0001213900-25-025889
Chunk: 136

Company: NewcelX Ltd.
Filing Date: 2025-03-31
Form: 425
Chunk 136
---
 the maximum number of shares of ordinary shares issued and issuable upon exercise of the related Warrants as of
the trading day immediately preceding the date the registration statement is initially filed with the SEC. The fourth column assumes the
sale of all of the shares offered by the selling stockholders pursuant to this prospectus.

Under the terms of the Preferred
Shares, a selling stockholder may not convert the Preferred Shares to the extent such exercise would cause such selling stockholder, together
with its affiliates, to beneficially own a number of Common Shares which would exceed 9.99% of our then outstanding Common Shares following
such conversion. Under the terms of the Warrants, a selling stockholder may not exercise the Warrants to the extent such exercise would
cause such selling stockholder, together with its affiliates, to beneficially own a number of shares of ordinary shares which would exceed
9.99% of our then outstanding shares of ordinary shares following such exercise, excluding for purposes of such determination shares of
ordinary shares issuable upon exercise of the Warrants which have not been exercised. The number of shares in the second column does not
reflect these limitations. The selling stockholders may sell all, some or none of their shares in this offering. See “Plan of Distribution.”

| Name of Selling Shareholder |     | Number of      
 Common Shares  
 Owned Prior to 
 Offering       |     | Maximum Number      
 of Common Shares    
 to be Sold Pursuant 
 to this Prospectus  |     | Number of     
 Common Shares 
 Owned After   
 Offering      |

<div align='center'>PLAN OF DISTRIBUTION</div>

We are registering the Common
Shares that may be issued upon conversion of the Preferred Shares issued pursuant to the Securities Purchase Agreement and upon exercise
of the Warrants issued pursuant to the terms of the Securities Purchase Agreement to permit the resale of these Common Shares by the holders
of such shares and Warrants from time to time after the date of this prospectus. We will not receive any of the proceeds from the sale
by the selling stockholders of the Common Shares. We will bear all fees and expenses incident to our obligation to register the Common
Shares.

The selling stockholders may
sell all or a portion of the Common Shares beneficially owned by them and offered hereby from time to time directly or through one or
more underwriters, broker-dealers or agents. If the Common Shares are sold through underwriters or broker-dealers, the selling stockholders
will be responsible for underwriting discounts or commissions or